REMEDIUM LIFECARE
|
|
BOM : 539561     NSE :      | |
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive] Debt : High |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward Pledged Shares : None or < 25% |
Jun 06,2025 |
Price(EOD): ₹ 1.36
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Trading |
MCap: ₹ 119.95 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
REMEDIUM LIFECARE | -17.6% | -21.4% | -89.6% |
ADANI ENTERPRISES | 0.6% | 10.9% | -31.3% |
REDINGTON | 4.8% | 14% | 35.6% |
MMTC | -5.6% | 39.5% | 4.1% |
HONASA CONSUMER | 1.6% | 29.5% | -31.1% |
LLOYDS ENTERPRISES | 15.9% | 44.2% | 96.1% |
ENTERO HEALTHCARE SOLUTIONS | -1.3% | -9.9% | 19% |
OPTIEMUS INFRACOM | -4% | 19.1% | 136.9% |
POLO QUEEN INDUSTRIAL & FINTECH | -3.4% | -8% | 33.8% |
FUNDAMENTAL ANALYSIS OF REMEDIUM LIFECARE
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF REMEDIUM LIFECARE
 Ratio | Standalone | |
---|---|---|
P/E P/B P/S |
78.4
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 1.53 Cr
[Latest Qtr - Mar2025 - Standalone Results ] 2.79
P/B Calculated based on Book Value of Rs 42.96 Cr
[Latest Year - Mar2024 - Standalone Results ] 0.54
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Mar2025 - Standalone Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
119% 216% 258% |
SHARE PRICE MOMENTUM OF REMEDIUM LIFECARE
REMEDIUM LIFECARE vs SENSEX
DEBT OF REMEDIUM LIFECARE
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2024 2023 2022 Avg_3yrs |
1.34 0 0 0.45 |
- - - - |
[Last Annual Data : Mar2024]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF REMEDIUM LIFECARE
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Mar2025 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF REMEDIUM LIFECARE
Standalone | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
113.81% 78.51% -300.38% -446.4% |
-94.21% 96.64% 94.11% 95.08% |
QtrlyTrend |
2 | |
Latest Qtr: Mar2025 | ||
Quarterly Result Analysis → |
REMEDIUM LIFECARE related INDICES
You may also like the below Video Courses
FAQ about REMEDIUM LIFECARE
Is REMEDIUM LIFECARE good for long term investment?
As on Jun 06,2025, the Fundamentals of REMEDIUM LIFECARE look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of REMEDIUM LIFECARE . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is REMEDIUM LIFECARE UnderValued or OverValued?
As on Jun 06,2025, REMEDIUM LIFECARE is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of REMEDIUM LIFECARE ?
As on Jun 06,2025, the Intrinsic Value of REMEDIUM LIFECARE is Rs. 0.43 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 0.62
Fair Value [Median EV / Sales Model] : Rs. 0.43
Fair Value [Median Price / Sales Model] : Rs. 0.38
Estimated Median Fair Value of REMEDIUM LIFECARE : Rs. 0.43
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.
Is REMEDIUM LIFECARE trading at a Premium or Discount?
As on Jun 06,2025, REMEDIUM LIFECARE is trading at a Premium of 217% based on the estimates of Median Intrinsic Value!ADANI ENTERPRISES LTD vs REDINGTON LTD vs MMTC LTD
HONASA CONSUMER LTD vs LLOYDS ENTERPRISES LTD vs ENTERO HEALTHCARE SOLUTIONS LTD